Cite
Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
MLA
Mami Ogita, et al. “Phase II Study of Stereotactic Body Radiotherapy with Hydrogel Spacer for Prostate Cancer: Acute Toxicity and Propensity Score-Matched Comparison.” Radiation Oncology, vol. 16, no. 1, June 2021, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s13014-021-01834-1.
APA
Mami Ogita, Hideomi Yamashita, Yuki Nozawa, Sho Ozaki, Subaru Sawayanagi, Takeshi Ohta, & Keiichi Nakagawa. (2021). Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison. Radiation Oncology, 16(1), 1–11. https://doi.org/10.1186/s13014-021-01834-1
Chicago
Mami Ogita, Hideomi Yamashita, Yuki Nozawa, Sho Ozaki, Subaru Sawayanagi, Takeshi Ohta, and Keiichi Nakagawa. 2021. “Phase II Study of Stereotactic Body Radiotherapy with Hydrogel Spacer for Prostate Cancer: Acute Toxicity and Propensity Score-Matched Comparison.” Radiation Oncology 16 (1): 1–11. doi:10.1186/s13014-021-01834-1.